Company intelligence

ACXP

Acurx Pharmaceuticals, Inc. · NASDAQ · Healthcare

Price$1.16-3.33% · −$0.04

Market cap4.99MEquity value

P / E-0.4Trailing ratio

Volume53.4KLatest session

Market data

ACXP price chart

TradingView

Related signals

1 min delayed

Browse public ACXP signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ACXPMar 11, 2026-13.37% since signal

Acurx Pharmaceuticals shares jump on ibezapolstat progress news

Acurx Pharmaceuticals (ACXP) shares surged following a recent press release about their lead antibiotic candidate, ibezapolstat. This uptick reflects strong investor sentiment and optimism surrounding the drug's development, indicating potential for further price momentum in the near term.

View signal analysis

ACXPNov 20, 2024-4.41% since signal

Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy's playbook

Acurx Pharmaceuticals approved purchasing $1 million in bitcoin as treasury asset. ACXP shares dipped over 6% after an 8% premarket surge. CEO highlights bitcoin's limited supply as a strong store of value. Companies like MicroStrategy see significant stock gains from bitcoin investments. Bitcoin's price increased by 122% this year, signaling growing investor interest.

View signal analysis

Research